US equities
|
NVDA
$242.69
▲+1.59%
SPCX
$173.72
▲+1.53%
MU
$1,060.22
▼-0.35%
AMD
$636.00
▲+0.67%
META
$742.92
▲+0.14%
MRVL
$278.44
▲+2.65%
SNDK
$1,702.66
▼-0.09%
AMZN
$251.61
▲+0.08%
NVDA
$242.69
▲+1.59%
SPCX
$173.72
▲+1.53%
MU
$1,060.22
▼-0.35%
AMD
$636.00
▲+0.67%
META
$742.92
▲+0.14%
MRVL
$278.44
▲+2.65%
SNDK
$1,702.66
▼-0.09%
AMZN
$251.61
▲+0.08%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about BOVNF
Recent news which mentions BOVNF
Exelixis-BioInvent Establish Immuno-Oncology Pact
June 16, 2022
Tickers
BOVNF
EXEL
Tags
General
EXEL
Contracts
From
Benzinga
Casi Pharma-Partnered BioInvent's Lead Cancer Program Gets FDA Orphan Drug Tag
January 20, 2022
Tickers
BOVNF
CASI
MRK
Tags
Benzinga
News
FDA
From
Benzinga